Accession 277
Title Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
Summary To investigate potential mechanisms for this antiproliferative response in the combinatorial therapy, we performed Human Phospho-Kinase Antibody Array analysis, measuring the relative phosphorylation levels of 39 intracellular proteins in untreated, cetuximab, dasatinib or the combinatorial treatment in the KRAS mutant lines LS180, LoVo and HCT116 cells.
Journal Oncogene
Publish date October, 2010
Corresponding Author D L Wheeler
Array Type Antibody array
Species Homo sapiens
Raw data link No relevant experiment link!
Link to PubMed

PubMed ID:20956938